Farshad Guirakhoo - 03 May 2022 Form 4 Insider Report for Vaxxinity, Inc.

Role: Chief Scientific Officer
Signature: Rene Paula Molina, attorney-in-fact for Farshad Guirakhoo
Issuer symbol: VAXX on OTC
Transactions as of: 03 May 2022
Net transactions value: +$5,700
Form type: 4
Filing time: 05 May 2022, 13:39:35 UTC
Previous filing: 29 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VAXX	Class A common stock	Options Exercise	$5,700	+10,000		$0.5700^*	10,000	03 May 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VAXX	Stock Option (right to buy)	Options Exercise	$0	-10,000	-7.9%	$0.000000	116,730	03 May 2022	Class A common stock	10,000	$0.5700	Direct	F1
holding	VAXX	Stock Option (right to buy)						41,958	03 May 2022	Class A common stock	41,958	$13.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options are subject to a four year time-based vesting schedule, with 25% vested on 6/5/2021 and the remainder vesting in equal installments each month during the remainder of the vesting period.
F2	These options are subject to a four-year time-vesting schedule, with 25% vesting on 11/11/2022 and the remainder vesting in equal installments each month during the remainder of the vesting period.